SS
VRTX icon

SBI Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

SBI Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
1,270
+33
+3% +$14.6K 0.01% 368
2026
Q1 		$552K Sell
1,237
-82
-6% -$38.2K 0.02% 379
2025
Q4 		$598K Sell
1,319
-127
-9% -$54.7K 0.02% 360
2025
Q3 		$566K Sell
1,446
-42
-3% -$17.6K 0.01% 362
2025
Q2 		$662K Buy
1,488
+9
+0.6% +$4.15K 0.02% 322
2025
Q1 		$717K Sell
1,479
-32
-2% -$14.9K 0.02% 300
2024
Q4 		$608K Buy
+1,511
New +$700K 0.02% 318

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SBI Securities's VRTX Position: Q2 2026 in Review

SBI Securities increased its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q2 2026, buying an estimated $14.6K and bringing the position to 1,270 shares worth $631K. The position accounts for 0.01% of the portfolio, ranked #368.

SBI Securities first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $717K in Q1 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • SBI Securities held 1,270 shares of Vertex Pharmaceuticals worth $631K as of Q2 2026.
  • SBI Securities bought 33 Vertex Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
  • Vertex Pharmaceuticals made up 0.01% of SBI Securities's portfolio in Q2 2026, its #368 holding.
  • SBI Securities first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Vertex Pharmaceuticals position peaked at $717K in Q1 2025.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.